Home> Products> venlafaxine 37 5 mg for depression

{ "products": [ { "_id": "666c10e66641561b0446977f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393", "price": 58.0, "discountamount": 17.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "day", "GAD", "food", "life", "SNRI", "mood", "75mg", "need", "EMAIL", "water", "brain", "lives", "225mg", "37.5mg", "levels", "adults", "option", "control", "ability", "evening", "morning", "response", "patients", "Benefits", "sweating", "24 hours", "adherence", "intervals", "increments", "medication", "depression", "Venlafaxine", "information", "restlessness", "palpitations", "sterispharma", "sterisonline", "Introduction", "Key Features", "CALL/WHATSAPP", "starting dose", "panic disorder", "Initial Dosage", "patient safety", "steady release", "Anxiety Relief", "excessive worry", "dosage strength", "Improved Quality", "physical symptoms", "treatment regimen", "Regular monitoring", "Dosage adjustments", "Maintenance Dosage", "therapeutic efficacy", "Continued Monitoring", "multiple daily doses", "long-term management", "Antidepressant Action", "overall effectiveness", "usual maintenance dose", "potential side effects", "social anxiety disorder", "favorable safety profile", "VELAXFINE XR 37.5 therapy", "various anxiety disorders", "consistent symptom relief", "major depressive disorder", "VELAXFINE XR 37.5 capsules", "gastrointestinal discomfort", "Administration Instructions", "Extended-Release Formulation", "generalized anxiety disorder", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1910, "imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:44:06.065Z", "updatedon": "2024-06-27T07:29:09.447Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 37.5 ", "category": "NEUROLOGY RANGE", "tags": [ "venlafaxine 37.5 mg", "VELAXFINE XR 37.5", "", "VELAXFINE XR 37.5 side effects", "venlafaxine 37.5mg used for", "venlafaxine urinary side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f5fda0785a91af4b943c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nVelaxfine XR 37.5 contains Venlafaxine 37.5mg, a medication used to treat depression, anxiety disorders, and panic attacks. It belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs), which work by restoring the balance of neurotransmitters in the brain. Velaxfine XR 37.5 is formulated as an extended-release tablet, ensuring a gradual release of the medication throughout the day for sustained therapeutic effects. Common side effects may include nausea, dizziness, drowsiness, dry mouth, and constipation. It's important to follow your doctor's dosage instructions and report any severe side effects promptly.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n", "price": 58.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "brain", "SNRIs", "class", "doctor", "nausea", "balance", "dizziness", "dry mouth", "drowsiness", "depression", "medication", "constipation", "VELAXFINE XR", "panic attacks", "gradual release", "neurotransmitters", "anxiety disorders", "Venlafaxine 37.5mg", "dosage instructions", "severe side effects", "Common side effects", "extended-release tablet", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 802, "imageuri": "https://productimages.withfloats.com/actual/662f5fdcf86c61bb176545ca.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f5fdcf86c61bb176545ca.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T08:52:42.588Z", "updatedon": "2024-06-12T12:58:57.274Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/802", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Venlafaxine (37.5mg)", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67e1547f527b20030c4156f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 5 mg and Metformin Hydrochloride 500 mg", "description": "EMPATECH MET 5/500 is a powerful combination of Empagliflozin 5 mg and Metformin Hydrochloride 500 mg designed to effectively manage Type 2 Diabetes Mellitus. It helps control blood sugar levels, improves insulin sensitivity, and reduces the risk of diabetes-related complications. This dual-action formula works by limiting glucose absorption while enhancing the body's natural ability to utilize insulin, making it a preferred choice for diabetic patients seeking optimal glycemic control.\n \nKey Benefits:\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains stable glucose levels.\nSupports Weight Management – Promotes calorie loss by eliminating excess glucose.\nReduces Cardiovascular Risk – Empagliflozin has heart-protective benefits, reducing the risk of heart-related complications.\nImproves Insulin Sensitivity – Helps the body use insulin more effectively.\nReduces the Risk of Hypoglycemia – Lowers blood sugar without excessive insulin spikes.\n\nHow Does It Work?\n\nEmpagliflozin blocks the SGLT2 (Sodium-Glucose Co-Transporter 2) in the kidneys, preventing glucose reabsorption and allowing excess sugar to be excreted through urine.\nMetformin decreases glucose production in the liver and enhances insulin sensitivity, helping the body use glucose more efficiently.\nTogether, they provide comprehensive diabetes management by regulating blood sugar without causing significant hypoglycemia.\n \nDirections for Use:\n \n\nTake EMPATECH MET 5/500 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably with meals to minimize stomach discomfort.\n\nMaintain a balanced diet and regular exercise for optimal results.\n\nDo not stop or change the dosage without consulting your doctor.\n\n \nSide Effects:\n \n\nWhile EMPATECH MET 5/500 is generally well-tolerated, some individuals may experience:\n\nFrequent Urination – Due to glucose excretion in urine.\nMild Stomach Discomfort – Including nausea, bloating, or diarrhea.\nDizziness or Weakness – Especially in the initial stages of treatment.\nUrinary Tract Infections (UTIs) – A possible side effect of increased glucose in urine.\nLactic Acidosis (Rare but Serious) – Symptoms include muscle pain, breathing difficulty, or extreme tiredness; seek medical attention if these occur.", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "effectively reduces", "increased glucose", "initial stages", "diarrhea dizziness", "nausea bloating", "glucose excretion", "generally welltolerated", "optimal results", "regular exercise", "balanced diet", "water preferably", "empatech met 5500", "preferred choice", "diabetesrelated complications", "powerful combination", "side effect", "doctor swallow", "empagliflozin 5mg", "doctor side effects", "limiting glucose absorption", "excessive insulin spikes", "utilize insulin making", "work empagliflozin blocks", "regulating blood sugar", "allowing excess sugar", "heartprotective benefits reducing", "bodys natural ability", "dualaction formula works" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2074, "imageuri": "https://productimages.withfloats.com/actual/67e15496bb48c9c5202ecea6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e15496bb48c9c5202ecea6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:47:59.972Z", "updatedon": "2025-03-27T12:53:02.808Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5-mg-and-metformin-hydrochloride-500-mg/2074", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH MET 5/500", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin + metformin combination brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35ad2c50c07ee3dcaceda", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2047, "imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:34:26.615Z", "updatedon": "2025-03-22T10:19:44.132Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "category": "", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a359d62a16e824ce228063", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (5mg) , Metformin Hydrochloride (1000mg)", "description": "GLIEMPAFLOZIN MET 5mg/1000mg is a combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (5mg) and Metformin Hydrochloride (1000mg), two powerful antidiabetic agents that work together to regulate blood sugar levels. This medication helps improve glycemic control, reduce insulin resistance, and lower the risk of diabetes-related complications when combined with a healthy diet and regular exercise.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control – Regulates blood glucose levels by decreasing sugar production and enhancing excretion.\n\nWeight Management – Empagliflozin helps in weight reduction by promoting calorie loss through urinary glucose excretion.\n\nReduced Cardiovascular Risks – Lowers the risk of heart disease in diabetic patients.\n\nImproved Insulin Sensitivity – Enhances the body's response to insulin and reduces insulin resistance.\n\nSupports Kidney Function – Helps prevent diabetes-related kidney complications.\n\nLowers the Risk of Hypoglycemia – Unlike some other diabetes medications, it reduces the chances of sudden blood sugar drops.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 5mg/1000mg combines two distinct yet complementary mechanisms of action:\n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks glucose reabsorption in the kidneys, causing excess sugar to be eliminated through urine, thereby lowering blood sugar levels.\n\nMetformin (Biguanide) – Works by decreasing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption. This results in overall better glycemic control.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN MET 5mg/1000mg once or twice daily as directed by your healthcare provider.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nIt is best taken with meals to minimize gastrointestinal side effects.\n\nFollow a balanced diet and engage in regular physical activity for optimal diabetes management.\n\nDo not skip doses or stop medication without consulting a doctor.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 5mg/1000mg is well-tolerated, some individuals may experience side effects such as:\n\nFrequent urination (due to glucose excretion)\n\nDehydration and electrolyte imbalances\n\nGastrointestinal issues – Nausea, vomiting, diarrhea, or stomach discomfort\n\nUrinary tract infections (UTIs)\n\nGenital infections (yeast infections)\n\nLactic acidosis (rare but serious) due to metformin accumulation\n\nLow blood pressure (hypotension)", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "skip doses", "balanced diet", "complementary mechanisms", "hypoglycemia unlike", "bodys response", "heart disease", "weight reduction", "healthy diet", "diabetesrelated complications", "empagliflozin 5mg", "stop medication", "diabetes medications", "frequent urination due", "optimal diabetes management", "combination medication formulated", "glucose excretion dehydration", "experience side effects", "doctor side effects", "regular physical activity", "healthcare provider swallow", "gliempaflozin met 5mg1000mg", "glycemic control directions", "promoting calorie loss", "decreasing sugar production", "powerful antidiabetic agents", "metformin hydrochloride 1000mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2046, "imageuri": "https://productimages.withfloats.com/actual/67a359edd87a03335028ee95.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a359edd87a03335028ee95.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:30:14.031Z", "updatedon": "2025-03-27T09:44:28.311Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5mg-metformin-hydrochloride-1000mg-/2046", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 5mg/ 1000mg ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin/metformin 5 mg/500 mg", "empagliflozin + metformin combination brand name", "empagliflozin + metformin brand name in india", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35767912e6c5ba00a1473", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (5mg) ,Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET is an advanced oral medication designed for the effective management of Type 2 Diabetes Mellitus. This combination of Empagliflozin (5mg) and Metformin Hydrochloride (500mg) helps regulate blood sugar levels, improve insulin sensitivity, and reduce the risk of diabetes-related complications. It is commonly prescribed as part of a comprehensive diabetes care plan, including diet and lifestyle modifications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable blood glucose levels.\nReduces Insulin Resistance – Enhances the body's ability to utilize insulin efficiently.\nPromotes Weight Management – Empagliflozin aids in weight loss by eliminating excess glucose.\nImproves Cardiovascular Health – Lowers the risk of heart disease in diabetic patients.\nSupports Kidney Function – Helps reduce the progression of diabetic kidney disease.\nLower Risk of Hypoglycemia – Unlike some other diabetes medications, it has a lower risk of causing dangerously low blood sugar levels.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET combines two powerful antidiabetic agents to provide synergistic effects:\n\nEmpagliflozin (SGLT2 Inhibitor): Blocks glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood glucose levels effectively.\nMetformin (Biguanide): Works by decreasing glucose production in the liver and improving insulin sensitivity, leading to better glucose utilization by body tissues.\nTogether, these mechanisms help in long-term diabetes management, reducing complications and improving overall well-being.\n\n \nDirections for Use:\n \n\nTake one tablet as prescribed by your healthcare provider.\nPreferably consume with meals to minimize stomach discomfort.\nSwallow the tablet whole with water; do not crush or chew.\nMaintain a healthy diet and exercise routine for optimal results.\nRegular blood sugar monitoring is recommended to track progress.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nIncreased urination\nMild dehydration\nWeakness or dizziness\nSerious Side Effects (Seek Medical Attention):\n\nKetoacidosis: Unusual fatigue, nausea, vomiting, or breathing difficulties.\nUrinary Tract Infections (UTIs): Burning sensation while urinating, fever, or pelvic pain.\nLactic Acidosis (Rare but Severe): Muscle pain, trouble breathing, irregular heartbeat.\nIf any severe reactions occur, consult a doctor immediately.", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "healthy diet", "commonly prescribed", "doctor immediately", "urinating fever", "generally welltolerated", "gliempaflozin met", "exercise routine", "chew maintain", "wellbeing directions", "body tissues", "diabetes medications", "hypoglycemia unlike", "heart disease", "weight loss", "bodys ability", "diabetesrelated complications", "empagliflozin 5mg", "effective management", "glucose utilization", "decreasing glucose production", "powerful antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2043, "imageuri": "https://productimages.withfloats.com/actual/67a35783a4575f9364b319c7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35783a4575f9364b319c7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:19:51.149Z", "updatedon": "2025-03-22T10:21:42.769Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5mg-metformin-hydrochloride-500mg-/2043", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 5MG/ 500MG ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin combination brand name", "Empagliflozin and metformin hydrochloride tablets", "empagliflozin + metformin brand name in india", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }